_id
6913142fccc777a4e85d7fe4
Ticker
MDCXW
Name
Medicus Pharma Ltd. Warrant
Exchange
NASDAQ
Address
300 Conshohocken State Road, Conshohocken, PA, United States, 19428
Country
USA
Sector
Industry
Currency
USD
Website
https://medicuspharma.com
Description
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. Medicus Pharma Ltd. has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in Conshohocken, Pennsylvania.
Last Close
2.5
Volume
-
Current Price
0.8172
Change
-4.7383397253494985
Last Updated
2026-01-05T10:16:25.519Z
Image
data:image/webp;base64,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
Ipo Date
2024-11-14T00:00:00.000Z
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
6708865
Operating Income
-6708865
Interest Expense
11572
Pretax Income
-15981312
Net Income
-15981389
Eps
-0.857754066892991
Dividends Per Share
4954518
Shares Outstanding
0
Income Tax Expense
-
EBITDA
-15981312
Operating Margin
-
Total Other Income Expense Net
-9272447
Cash
8662091
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
9781412
Property Plant Equipment
196249
Total Assets
9977661
Payables
2027509
Short Term Debt
141070
Long Term Debt
29462
Total Liabilities
10782551
Equity
-910126
Bs_currency_symbol
USD
Depreciation
-
Change In Working Capital
-1360764
Cash From Operations
-6832069
Capital Expenditures
0.75
Cash From Investing
-4689440
Cash From Financing
10483764
Net Change In Cash
-1007455
Cf_currency_symbol
USD
PE
-
PB
-16.729330982303548
ROE
1755.9534613888627
ROA
-160.1716975551685
FCF
-6832069.75
Fcf Percent
-
Piotroski FScore
1
Health Score
39
Deep Value Investing Score
0.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
5.8
Garp Investing Score
2
Growth Investing Score
2
Momentum Investing Score
5
Net Net Investing Score
0
Quality Investing Score
3
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
6708865
Quarters > 0 > income Statement > operating Income
-6708865
Quarters > 0 > income Statement > interest Expense
11572
Quarters > 0 > income Statement > pretax Income
-15981312
Quarters > 0 > income Statement > net Income
-15981389
Quarters > 0 > income Statement > eps
-0.857754066892991
Quarters > 0 > income Statement > dividends Per Share
4954518
Quarters > 0 > income Statement > shares Outstanding
18631668
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-15981312
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-9272447
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
8662091
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
9781412
Quarters > 0 > balance Sheet > property Plant Equipment
196249
Quarters > 0 > balance Sheet > total Assets
9977661
Quarters > 0 > balance Sheet > payables
2027509
Quarters > 0 > balance Sheet > short Term Debt
141070
Quarters > 0 > balance Sheet > long Term Debt
29462
Quarters > 0 > balance Sheet > total Liabilities
10782551
Quarters > 0 > balance Sheet > equity
-910126
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-15981389
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-1360764
Quarters > 0 > cash Flow > cash From Operations
-6832069
Quarters > 0 > cash Flow > capital Expenditures
0.75
Quarters > 0 > cash Flow > cash From Investing
-4689440
Quarters > 0 > cash Flow > cash From Financing
10483764
Quarters > 0 > cash Flow > net Change In Cash
-1007455
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.857754066892991
Quarters > 0 > ratios > PB
-16.729330982303548
Quarters > 0 > ratios > ROE
1755.9534613888627
Quarters > 0 > ratios > ROA
-160.1716975551685
Quarters > 0 > ratios > FCF
-6832069.75
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
39
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
6016088
Quarters > 1 > income Statement > operating Income
-6016088
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-6176084
Quarters > 1 > income Statement > net Income
-6176084
Quarters > 1 > income Statement > eps
-0.43236986498636504
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
14284261
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-6016088
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-159996
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
9669546
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
10996731
Quarters > 1 > balance Sheet > property Plant Equipment
220999
Quarters > 1 > balance Sheet > total Assets
11934628
Quarters > 1 > balance Sheet > payables
1770178
Quarters > 1 > balance Sheet > short Term Debt
4824402
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
8685918
Quarters > 1 > balance Sheet > equity
3248710
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-6176084
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
253988
Quarters > 1 > cash Flow > cash From Operations
-5468831
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
11155947
Quarters > 1 > cash Flow > net Change In Cash
5687116
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.43236986498636504
Quarters > 1 > ratios > PB
3.593148692619532
Quarters > 1 > ratios > ROE
-190.10881242093015
Quarters > 1 > ratios > ROA
-51.74927949157695
Quarters > 1 > ratios > FCF
-5468831
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
24
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
5126274
Quarters > 2 > income Statement > operating Income
-5126274
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-5102408
Quarters > 2 > income Statement > net Income
-5102408
Quarters > 2 > income Statement > eps
-0.4168485161109853
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
12240437
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-5102408
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
23866
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
3982623
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
14000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
5088021
Quarters > 2 > balance Sheet > property Plant Equipment
245102
Quarters > 2 > balance Sheet > total Assets
5658140
Quarters > 2 > balance Sheet > payables
2035364
Quarters > 2 > balance Sheet > short Term Debt
120301
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
3510482
Quarters > 2 > balance Sheet > equity
2147658
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-5102408
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
1025657
Quarters > 2 > cash Flow > cash From Operations
-3940994
Quarters > 2 > cash Flow > capital Expenditures
4
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
3759101
Quarters > 2 > cash Flow > net Change In Cash
-181893
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.4168485161109853
Quarters > 2 > ratios > PB
4.657578216084684
Quarters > 2 > ratios > ROE
-237.58009887980302
Quarters > 2 > ratios > ROA
-90.1781857642264
Quarters > 2 > ratios > FCF
-3940998
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
28
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
156966
Quarters > 3 > income Statement > cost Of Revenue
78483
Quarters > 3 > income Statement > gross Profit
78483
Quarters > 3 > income Statement > operating Expenses
2350705
Quarters > 3 > income Statement > operating Income
-2350705
Quarters > 3 > income Statement > interest Expense
796110
Quarters > 3 > income Statement > pretax Income
-2274581
Quarters > 3 > income Statement > net Income
-2274581
Quarters > 3 > income Statement > eps
-0.19248833919324998
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
11816721
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-1478471
Quarters > 3 > income Statement > operating Margin
-1497.588649771288
Quarters > 3 > income Statement > total Other Income Expense Net
76124
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
4161845
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
5375107
Quarters > 3 > balance Sheet > property Plant Equipment
268411
Quarters > 3 > balance Sheet > total Assets
5643519
Quarters > 3 > balance Sheet > payables
1284612
Quarters > 3 > balance Sheet > short Term Debt
116253
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
2510679
Quarters > 3 > balance Sheet > equity
3132839
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-2274581
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
-1098901
Quarters > 3 > cash Flow > cash From Operations
-3045235
Quarters > 3 > cash Flow > capital Expenditures
4.98
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
1867576
Quarters > 3 > cash Flow > net Change In Cash
-1141836
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.19248833919324998
Quarters > 3 > ratios > PB
3.082387700485087
Quarters > 3 > ratios > ROE
-72.60446515125737
Quarters > 3 > ratios > ROA
-40.30430304212673
Quarters > 3 > ratios > FCF
-3045239.98
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-19.400634404902974
Quarters > 3 > health Score
25
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
11180902
Annuals > 0 > income Statement > operating Income
-11180902
Annuals > 0 > income Statement > interest Expense
902362
Annuals > 0 > income Statement > pretax Income
-11155516
Annuals > 0 > income Statement > net Income
-11155516
Annuals > 0 > income Statement > eps
-0.9440449681430237
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
11816721
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-11155516
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
25385
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
4161845
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
5375107
Annuals > 0 > balance Sheet > property Plant Equipment
268411
Annuals > 0 > balance Sheet > total Assets
5643519
Annuals > 0 > balance Sheet > payables
1284612
Annuals > 0 > balance Sheet > short Term Debt
116253
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
2510679
Annuals > 0 > balance Sheet > equity
3132839
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-11155516
Annuals > 0 > cash Flow > depreciation
-
Annuals > 0 > cash Flow > change In Working Capital
32927
Annuals > 0 > cash Flow > cash From Operations
-10247231
Annuals > 0 > cash Flow > capital Expenditures
1.95
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
12692216
Annuals > 0 > cash Flow > net Change In Cash
2444985
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.9440449681430237
Annuals > 0 > ratios > PB
9.429722529628876
Annuals > 0 > ratios > ROE
-356.0832842032419
Annuals > 0 > ratios > ROA
-197.66950372630978
Annuals > 0 > ratios > FCF
-10247232.95
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
22
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
4729945
Annuals > 1 > income Statement > operating Income
-4729945
Annuals > 1 > income Statement > interest Expense
595544
Annuals > 1 > income Statement > pretax Income
-5314765
Annuals > 1 > income Statement > net Income
-5314765
Annuals > 1 > income Statement > eps
-0.6580388979472117
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
8076673
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-4729945
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-584820
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
1719338
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
1893057
Annuals > 1 > balance Sheet > property Plant Equipment
0
Annuals > 1 > balance Sheet > total Assets
1893057
Annuals > 1 > balance Sheet > payables
210842
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
781609
Annuals > 1 > balance Sheet > equity
1111448
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-5314765
Annuals > 1 > cash Flow > depreciation
-
Annuals > 1 > cash Flow > change In Working Capital
473096
Annuals > 1 > cash Flow > cash From Operations
-4158264
Annuals > 1 > cash Flow > capital Expenditures
4
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
5609950
Annuals > 1 > cash Flow > net Change In Cash
1451686
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.6580388979472117
Annuals > 1 > ratios > PB
18.167006013776625
Annuals > 1 > ratios > ROE
-478.1838646522375
Annuals > 1 > ratios > ROA
-280.7503947319072
Annuals > 1 > ratios > FCF
-4158268
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
22
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
978416
Annuals > 2 > income Statement > operating Income
-978416
Annuals > 2 > income Statement > interest Expense
526825
Annuals > 2 > income Statement > pretax Income
-1692382
Annuals > 2 > income Statement > net Income
-1692382
Annuals > 2 > income Statement > eps
-0.3397800681655375
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
4980816
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-1165557
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-713966
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
267652
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
282652
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
282652
Annuals > 2 > balance Sheet > payables
-
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
12480684
Annuals > 2 > balance Sheet > equity
-12198032
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-1692382
Annuals > 2 > cash Flow > depreciation
-
Annuals > 2 > cash Flow > change In Working Capital
-78687
Annuals > 2 > cash Flow > cash From Operations
-1057103
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
1246241
Annuals > 2 > cash Flow > net Change In Cash
189138
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.3397800681655375
Annuals > 2 > ratios > PB
-1.0208236869685208
Annuals > 2 > ratios > ROE
13.874221677726375
Annuals > 2 > ratios > ROA
-598.7511144446173
Annuals > 2 > ratios > FCF
-1057103
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
25
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
1441388
Annuals > 3 > income Statement > operating Income
-1441388
Annuals > 3 > income Statement > interest Expense
115406
Annuals > 3 > income Statement > pretax Income
-2055263
Annuals > 3 > income Statement > net Income
-2055263
Annuals > 3 > income Statement > eps
-1.090383044193326
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
1884900
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-1939857
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-613875
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
78514
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
-
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
78514
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
78514
Annuals > 3 > balance Sheet > payables
-
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
10584164
Annuals > 3 > balance Sheet > equity
-10505650
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-2055263
Annuals > 3 > cash Flow > depreciation
-
Annuals > 3 > cash Flow > change In Working Capital
-6658
Annuals > 3 > cash Flow > cash From Operations
-1448046
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
882385
Annuals > 3 > cash Flow > net Change In Cash
-565661
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-1.090383044193326
Annuals > 3 > ratios > PB
-0.44854435470437337
Annuals > 3 > ratios > ROE
19.563406357531424
Annuals > 3 > ratios > ROA
-2617.7025753368825
Annuals > 3 > ratios > FCF
-1448046
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
29
Valuation > metrics > PE
-0.857754066892991
Valuation > metrics > PB
-16.729330982303548
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
1755.9534613888627
Profitability > metrics > ROA
-163.3852965195618
Profitability > final Score
55
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-579.7498271690287
Risk > final Score
-2289
Risk > verdict
High
Liquidity > metrics > Current Ratio
4.510516794638332
Liquidity > metrics > Quick Ratio
4.510516794638332
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
44.06851307380468
Prev Valuations > 1
33.42421783915316
Prev Valuations > 2
49.17612299514913
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
0
Prev Risks > 0
-132
Prev Risks > 1
50
Prev Risks > 2
36
Prev Liquidities > 0
92
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:11:24.974Z
Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. Medicus Pharma Ltd. has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in Conshohocken, Pennsylvania.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ATreasury Yields: Is LogicMark Inc stock a smart retirement pick - July 2025 Short Interest & Safe Entry Momentum Tips baoquankhu1.vn
Read more →Revenue Check: Why is EFSC stock going down - Trade Risk Assessment & Reliable Entry Point Alerts baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of Medicus Pharma Ltd. Warrant
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.